| TNBC | Triple-negative breast cancer |
| ICI | Immune checkpoint inhibitors |
| PD-L1 | Programmed death ligand 1 |
| TAMs | Tumor-associated macrophages |
| PCX | Paclitaxel (chemotherapy group) |
| ER | Estrogen receptor |
| PR | Progesterone receptor |
| HER2 | Human epidermal growth factor receptor 2 |
| FDA | Food and Drug Administration |
| MFI | Mean fluorescence intensity |
| H&E | Hematoxylin and eosin |
| SEM | Standard error of the mean |
| FBS | Fetal bovine serum |
| RPMI | Roswell Park Memorial Institute medium |
| BALB/c | Bagg albino laboratory-bred strain c (mouse strain) |
| CD | Cluster of differentiation |
| TCM | Central memory T cell |
| TEM | Effector memory T cell |
| αPD-L1 | Anti-PD-L1 monoclonal antibody |